Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial
Yazar
Lawson, J. A.
de Vries, P. J.
Curatolo, P.
Nabbout, R.
Polster, T.
French, J. A.
Ikeda, H.
Yapici, Z.
Franz, D. N.
Pelov, D.
Ridolfi, A.
Fan, J.
Voi, M.
Dlugos, D. J.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]